Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) therapeutics for weight loss, though it remains to be seen whether it changes their ...

This is read by an automated voice. Please report any issues or inconsistencies here. Ozempic, Zepbound, and Wegovy are now household names. And as these GLP-1 medications have exploded in popularity, ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. For the first time ever, the World Health Organization has ...

Previously hailed – or derided – as weight-loss aids for the rich and famous, drugs such as Mounjaro, Wegovy and Ozempic took on a far more expansive role in 2025. No longer just considered treatments ...

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the ...

GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs. By Emily Anthes In just a few short years, new diabetes and weight loss drugs like Ozempic, Wegovy ...

Two of the largest clinical trials of their kind have doused hopes that a diabetes and weight loss “wonder drug” might also work its magic on Alzheimer’s. A daily dose of oral semaglutide did not ...

Questions surround their effects on brain health, pregnancy or long-term use. MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand ...